Rate My Professor Neil Lambie

Lambie's academic career includes service as College Registrar for the Royal College of Pathologists of Australasia around 2014-2015 and participation in committees such as those for anatomical pathology trainees. His research focuses on diagnostic pathology, particularly in gynecological and oncological contexts, with 19 publications and over 400 citations. Notable works include 'SMARCA4-associated schwannomatosis' (Acta Neuropathologica, 2023); 'CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study' (Cancer, 2022); 'Differences in the Active Endometrial Microbiota across Body Weight and Cancer in Humans and Mice' (Cancers, 2022); 'MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma' (Virchows Archiv, 2021); 'Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3' (Pharmaceuticals, 2021); 'The Clinical Relevance of p16 and p53 Status in Patients with Squamous Cell Carcinoma of the Vulva' (Journal of Oncology, 2020); 'A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases' (Modern Pathology, 2019); 'Degenerate-disc infection study with contaminant control (DISC): Application of a proposed histological scoring system' (Journal of Clinical Neuroscience, 2016); 'Looking beyond human papillomavirus (HPV) genotype 16 and 18' (International Journal of Cancer, 2017); and 'Pulmonary haemorrhage in a 13-year-old girl: An unusual presentation of systemic lupus erythematosus' (Postgraduate Medical Journal, 2009). These contributions advance understanding in tumor diagnostics, microbiota influences on cancer, and histopathological markers.